Mid-term efficacy of prostatic artery embolization for benign prostatic hyperplasia
10.3760/cma.j.cn112149-20210303-00183
- VernacularTitle:前列腺动脉栓塞治疗良性前列腺增生的中期疗效分析
- Author:
Zhongwei XU
1
;
Chungao ZHOU
;
Wei TIAN
;
Bin LENG
;
Haibin SHI
;
Sheng LIU
Author Information
1. 南京医科大学第一附属医院介入放射科 210029
- Keywords:
Prostatic hyperplasia;
Prostatic artery embolization;
Lower urinary tract symptoms;
Urinary retention;
Hematuria
- From:
Chinese Journal of Radiology
2021;55(11):1197-1201
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the mid-term efficacy of prostatic artery embolization (PAE) for the treatment of lower urinary tract symptoms (LUTS), urinary retention (UR) or hematuria secondary to benign prostatic hyperplasia (BPH).Methods:This was a retrospective study conducted from February 2014 to December 2018 in 140 patients who underwent PAE for LUTS, UR or hematuria secondary to BPH, including 85 patients with LUTS (60 patients with LUTS and 25 LUTS combined with hematuria), 52 patients with UR (50 patients with UR and 2 UR combined with hematuria) and 3 patients with hematuria. All patients were followed up for 24 months. Clinical success rates were evaluated. Friedman test was performed to compare the differences in International Prostate Symptom Score (IPSS), quality of life (QoL) score, and prostatic volume (PV) between baseline and follow-up time points (3, 6, 12 and 24 months). A post hoc test was performed by the Bonferroni method.Results:Significant differences in IPSS, QoL score and PV between baseline and follow-up time points were observed in 85 patients with LUTS ( P<0.001 for all), and clinical success rates at 3, 6, 12, 24 months after PAE were 95.3% (81/85), 91.8% (78/85), 87.1%(74/85), 83.5%(71/85). The success rate of extubation in patients with UR within 1 month after PAE was 98.1% (51/52). The average interval from PAE to catheter-independence was (6.8±3.7) days, and clinical success rates were 94.1% (48/51), 92.2% (47/51), 88.2% (45/51), 84.3% (43/51), respectively. The interval from PAE to the resolution of hematuria was (3.4±2.5) days, and clinical success rates were 90.0%(27/30), 90.0%(27/30), 83.3%(25/30), 80.0%(24/30), respectively. Conclusions:PAE was an effective treatment option for symptoms secondary to BPH in mid-term follow up.
